Literature DB >> 31567464

Practical Application of "About Herbs" Website: Herbs and Dietary Supplement Use in Oncology Settings.

Yen-Nien Hou1, Gary Deng, Jun J Mao.   

Abstract

The Integrative Medicine Service at Memorial Sloan Kettering Cancer Center developed and maintains About Herbs (www.aboutherbs.com), which provides summaries of research data including purported uses, adverse effects, and herb-drug interactions for about 284 dietary supplements. Using Google Analytics, we found the website registered more than 26,317,000 hits since November 2002. The 10 most searched-for herbs/supplements of 2018 are chaga mushroom, turmeric, ashwagandha, reishi mushroom, graviola, Active Hexose-Correlated Compound, boswellia, dandelion, green tea, and Coriolus versicolor. Here we discuss their safety, herb-drug interactions, and appropriate uses in the oncology setting, based on literature searches in PubMed. Over the past 16 years, the evidence for use of these supplements is based mostly on preclinical findings, with few well-designed studies and limited trials conducted in cancer patients. It is important to familiarize health care professionals about popular supplements, so patients can be informed to make decisions that maximize benefits and minimize risks.

Entities:  

Year:  2019        PMID: 31567464      PMCID: PMC6777855          DOI: 10.1097/PPO.0000000000000403

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  147 in total

1.  Active hexose correlated compound enhances resistance to Klebsiella pneumoniae infection in mice in the hindlimb-unloading model of spaceflight conditions.

Authors:  Hernan Aviles; Tesfaye Belay; Kimberly Fountain; Monique Vance; Buxiang Sun; Gerald Sonnenfeld
Journal:  J Appl Physiol (1985)       Date:  2003-04-11

Review 2.  Approach to communicating with patients about the use of nutritional supplements in cancer care.

Authors:  Moshe Frenkel; Eran Ben-Arye; Constance D Baldwin; Victor Sierpina
Journal:  South Med J       Date:  2005-03       Impact factor: 0.954

3.  Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism.

Authors:  María P Torres; Satyanarayana Rachagani; Vinee Purohit; Poomy Pandey; Suhasini Joshi; Erik D Moore; Sonny L Johansson; Pankaj K Singh; Apar K Ganti; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-04-01       Impact factor: 8.679

4.  Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients.

Authors:  Chun-Kwok Wong; Yi-Xi Bao; Eliza Lai-Yi Wong; Ping-Chung Leung; Kwok Pui Fung; Christopher Wai Kei Lam
Journal:  Am J Chin Med       Date:  2005       Impact factor: 4.667

5.  Selective growth inhibition of human breast cancer cells by graviola fruit extract in vitro and in vivo involving downregulation of EGFR expression.

Authors:  Yumin Dai; Shelly Hogan; Eva M Schmelz; Young H Ju; Corene Canning; Kequan Zhou
Journal:  Nutr Cancer       Date:  2011-06-22       Impact factor: 2.900

6.  Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial.

Authors:  S Togni; G Maramaldi; A Bonetta; L Giacomelli; F Di Pierro
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015-04       Impact factor: 3.507

7.  Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer.

Authors:  Y Iino; T Yokoe; M Maemura; J Horiguchi; H Takei; S Ohwada; Y Morishita
Journal:  Anticancer Res       Date:  1995 Nov-Dec       Impact factor: 2.480

8.  Effects of spice constituents on P-glycoprotein-mediated transport and CYP3A4-mediated metabolism in vitro.

Authors:  Wenxia Zhang; Lee-Yong Lim
Journal:  Drug Metab Dispos       Date:  2008-04-02       Impact factor: 3.922

9.  Effect of Withania somnifera on CTL activity.

Authors:  L Davis; G Kuttan
Journal:  J Exp Clin Cancer Res       Date:  2002-03

10.  Antitumor activity of water extract of a mushroom, Inonotus obliquus, against HT-29 human colon cancer cells.

Authors:  Sung Hak Lee; Hee Sun Hwang; Jong Won Yun
Journal:  Phytother Res       Date:  2009-12       Impact factor: 5.878

View more
  4 in total

1.  Managing Patient Expectations: Integrative, Not Alternative.

Authors:  Shelly Latte-Naor
Journal:  Cancer J       Date:  2019 Sep/Oct       Impact factor: 3.360

2.  Diallyl Sulfide-Mediated Modulation of the Fatty Acid Synthase (FASN) Leads to Cancer Cell Death in BaP-Induced Lung Carcinogenesis in Swiss Mice.

Authors:  Arif Khan; Masood A Khan; Fahad A Alhumaydhi; Ameen S S Alwashmi; Khaled S Allemailem; Mohammed A Alsahli; Faris A Alrumaihi; Ahmad Almatroudi; Mugahid A Mobark; Ayman Mousa
Journal:  J Inflamm Res       Date:  2020-12-08

3.  Symptom burden and willingness to participate: implications for herbal clinical trials in lung cancer.

Authors:  Jie Liu; Wei Hou; Mithat Gönen; Christina Seluzicki; Susan Qing Li; Jun J Mao
Journal:  Ann Palliat Med       Date:  2020-12-17

4.  Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial.

Authors:  Jie Liu; Jun J Mao; Susan Qing Li; Hongsheng Lin
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.